🇺🇸 PTGX — Protagonist Therapeutics, Inc.
Salud Compra fuertePrecio actual
140,24 USD
Máx. histórico
158,62
78 días
Caída desde máximo
-11,59%
Rango 52 semanas
75,44 – 160,81
Variación hoy
+0,62%
Cierre anterior
139,37
Rango de hoy
139,91 – 144,27
Volumen hoy
673.087
Peor caída histórica
-85,79%
01/09/2021 → 13/06/2022
Recuperado en 1001 días
Volatilidad anualizada ⓘ
89,34%
- Nombre completo
- Protagonist Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 141
- PER ⓘ
- 136,16 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 178,57 USD (puede no estar actualizado)
- Primera cotización
- 11/08/2016
- Precio actualizado
- hace 10 horas
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/09/2016 | 12,40 | 12,40 | 12,05 | 12,40 | +0,00% | 2,82% | 49.300 |
| 09/09/2016 | 12,70 | 12,95 | 11,69 | 12,40 | -1,35% | 9,91% | 68.600 |
| 08/09/2016 | 12,79 | 12,79 | 12,43 | 12,57 | -0,48% | 2,81% | 72.500 |
| 07/09/2016 | 12,60 | 12,68 | 12,20 | 12,63 | +0,72% | 3,81% | 122.000 |
| 06/09/2016 | 12,01 | 13,00 | 11,72 | 12,54 | +3,81% | 10,66% | 116.200 |
| 02/09/2016 | 11,88 | 12,15 | 11,61 | 12,08 | -0,08% | 4,56% | 22.800 |
| 01/09/2016 | 12,01 | 12,41 | 11,74 | 12,09 | +0,67% | 5,58% | 41.700 |
| 31/08/2016 | 10,65 | 12,35 | 10,65 | 12,01 | +9,78% | 15,96% | 225.000 |
| 30/08/2016 | 10,30 | 11,42 | 10,30 | 10,94 | +3,01% | 10,85% | 117.800 |
| 29/08/2016 | 10,83 | 11,07 | 10,11 | 10,62 | +1,72% | 8,86% | 179.700 |
| 26/08/2016 | 10,80 | 11,40 | 10,08 | 10,44 | -2,52% | 12,22% | 115.200 |
| 25/08/2016 | 11,00 | 11,20 | 10,02 | 10,71 | -2,10% | 10,73% | 57.900 |
| 24/08/2016 | 11,33 | 11,50 | 10,74 | 10,94 | -4,70% | 6,71% | 66.600 |
| 23/08/2016 | 11,65 | 11,68 | 10,64 | 11,48 | -1,03% | 8,92% | 85.500 |
| 22/08/2016 | 11,45 | 11,75 | 11,10 | 11,60 | -1,69% | 5,68% | 35.900 |
| 19/08/2016 | 11,71 | 12,89 | 11,51 | 11,80 | +1,29% | 11,78% | 187.300 |
| 18/08/2016 | 11,84 | 11,89 | 11,50 | 11,65 | -0,77% | 3,30% | 63.300 |
| 17/08/2016 | 11,58 | 11,80 | 11,54 | 11,74 | +2,44% | 2,25% | 141.500 |
| 16/08/2016 | 11,50 | 11,69 | 11,46 | 11,46 | -0,35% | 2,00% | 52.100 |
| 15/08/2016 | 11,60 | 11,70 | 11,40 | 11,50 | -0,61% | 2,59% | 90.900 |
| 12/08/2016 | 11,75 | 12,00 | 11,28 | 11,57 | -1,11% | 6,13% | 120.000 |
| 11/08/2016 | 12,00 | 12,00 | 11,20 | 11,70 | — | 6,67% | 1.632.000 |